Governor Hochul Slams Federal Medicare Cuts That Raise Drug Costs for 1.3M New Yorkers
As federal policy changes threaten health coverage and drive up out-of-pocket expenses, New York leaders push back to protect seniors and working families.
Prescription counters across New York are becoming the front lines of a major financial battle for older adults and working families. Surging Medicare prescription drug costs threaten to force more than 1.3 million enrollees to choose between filling vital prescriptions and paying for essential living expenses like groceries or heat.
Governor Kathy Hochul has issued a sharp rebuke against recent federal policy decisions and proposed budget cuts, warning that stripping funding from senior health programs will devastate local communities. As health plans adjust to shifting federal regulations and reduced subsidies, state officials are scrambling to build a financial firewall to protect vulnerable enrollees throughout Central New York, the Mohawk Valley, and beyond.
What Are Medicare Prescription Drug Costs?
Definition: Medicare prescription drug costs refer to the out-of-pocket expenses—including monthly plan premiums, annual deductibles, copayments, and coinsurance—that Medicare beneficiaries pay to obtain covered prescription medications under Medicare Part D or Medicare Advantage plans.
The Scope of the Crisis: 1.3 Million New Yorkers in the Crosshairs
The financial impact of federal health cuts extends far beyond abstract policy debates in Washington. For millions of New Yorkers living on fixed incomes, even minor adjustments to subsidy formulas translate into immediate price spikes at the pharmacy.
IMPACT OF FEDERAL HEALTHCARE FUNDING CUTS IN NY
+-----------------------------------------------------------------+
| Affected Beneficiaries: ~1.3 Million New Yorkers |
| Projected Federal Shortfall: $7.5 Billion Statewide |
| Avg. Monthly Cost Surge: $228 – $270 in Upstate Regions |
+-----------------------------------------------------------------+
State data shows that federal policy shifts, including reductions in program funding under federal budget legislation and changes to continuous coverage waivers, endanger stability for low- and moderate-income residents. Without proactive state interventions, enrollees face:
-
Rising Monthly Premiums: Regional health plans in Upstate New York, including the Mohawk Valley and Finger Lakes, report projected monthly premium increases between 38% and 49%.
-
Higher Out-of-Pocket Deductibles: Beneficiaries must pay significantly more out of pocket before coverage begins for specialty medications.
-
Gaps in Coverage: Over 450,000 individuals transitioning between Essential Plan coverage and Medicare Part D risk temporary lapses in subsidized care.
Regional Financial Impact across New York State
The rising price of healthcare does not hit every region equally. Rural and Upstate enrollees often bear a disproportionate burden due to lower median fixed incomes and fewer regional plan choices.
| Region | Average Monthly Cost Increase (Couples) | Average Percentage Increase |
| Mohawk Valley | $270 | 49% |
| Central New York | $256 | 43% |
| Western New York | $267 | 38% |
| Capital Region | $231 | 33% |
| New York City | $211 | 38% |
| Statewide Average | $228 | 38% |
How Federal Cuts Threaten Local Families
For decades, federal subsidies helped stabilize Medicare prescription drug costs by capping out-of-pocket spending and absorbing sudden cost spikes from drug manufacturers. However, recent federal policy changes have reduced direct subsidies to state-run basic health programs and tightened eligibility parameters for continuous coverage.
Key Factors Driving the Price Increases
-
Federal Subsidy Reductions: Reductions in federal health allocations have created a projected $7.5 billion funding gap in state health programs.
-
Expiration of Enhanced Premium Credits: The failure to permanently extend federal tax credits forces plans to pass higher operating expenses onto enrollees.
-
PBM and Dispensing Costs: Complex administrative fees imposed by Pharmacy Benefit Managers (PBMs) continue to push retail drug prices upward.
“New York will not stand by while federal policies jeopardize healthcare access for our residents,” Governor Kathy Hochul stated during a recent health briefing. “When federal decisions drive up healthcare costs, it is our seniors and working families who pay the ultimate price. We are taking direct state action to protect coverage and keep life-saving medicine affordable.”
Balancing the Debate: Federal Fiscal Reality vs. Consumer Harm
To evaluate the situation fairly, it is essential to understand the rationale behind federal policy choices alongside their local consequences.
The Argument for Federal Cost Containment
Federal policymakers and fiscal conservatives argue that spending reductions are necessary to restrain the growing national deficit and preserve the long-term solvency of the overall Medicare Trust Fund. Proponents contend that:
-
Unchecked entitlement spending risks bankrupting core health programs within the next decade.
-
Reining in federal subsidies encourages state governments and private insurers to negotiate more aggressively with pharmaceutical manufacturers.
-
Policy adjustments encourage greater fiscal efficiency across state Medicaid and Medicare administration.
The Consumer Impact
Healthcare advocates and state leaders counter that sudden spending cuts do not eliminate healthcare costs—they merely shift them onto elderly citizens who cannot afford them.
-
Skipping doses of vital medications due to cost leads to preventable hospitalizations and higher long-term healthcare spending.
-
Seniors on fixed Social Security incomes cannot absorb sudden monthly increases of $200 or more without sacrificing basic necessities.
New York State’s Plan to Counteract the Cuts
In response to federal headwinds, New York State is utilizing administrative authority and state funds to shield enrollees from the worst financial shocks.
NEW YORK STATE ACTION PLAN
--------------------------
[1] NYRx Program Expansion
└─ Direct negotiation with drug manufacturers to lower prices.
[2] Basic Health Program Shield
└─ Transitioning 1.3M enrollees to preserve premium-free access.
[3] Expansion of CAPABLE & NORC Initiatives
└─ In-home care investments to prevent costly hospital visits.
-
Expanding NYRx Direct Negotiations: Expanding the Department of Health’s authority to negotiate supplemental rebates directly with drug manufacturers under the state’s NYRx framework.
-
Reverting the Essential Plan Structure: Submitting emergency requests to federal regulators (CMS) to modify state health insurance models, ensuring that 1.3 million lower-income enrollees retain low-cost coverage.
-
Investing in Upstream Senior Care: Allocating $35 million for non-medical in-home supports and expanding community aging initiatives like CAPABLE to keep seniors healthy in their own homes.
What Seniors and Families Can Do Now
If you or a loved one are concerned about rising Medicare prescription drug costs, take these proactive steps before open enrollment closes:
-
Review Your Plan Annual Notice of Change (ANOC): Compare your current plan’s drug formulary and co-pay tiers against upcoming year projections.
-
Explore Low-Income Subsidies (Extra Help): Contact local enrollment assisters to determine if you qualify for federal LIS or New York’s Elderly Pharmaceutical Insurance Coverage (EPIC) program.
-
Consult Local Navigators: Connect with trained counselors through the New York State of Health portal or local health services to explore alternative coverage options.
Conclusion: A Critical Moment for New York Healthcare
The conflict over federal health policy underscores a vital truth: healthcare affordability remains a central pillar of economic security for Central New York families. As state leaders fight to preserve coverage for 1.3 million enrollees and lower Medicare prescription drug costs, staying informed and proactive is the best defense against sudden price spikes.




